Analysis of an antimicrobial stewardship program at Montefiore Medical Center in the Bronx, N.Y., found a higher dose of oral vancomycin was no more effective than a low dose for treating Clostridium difficile infections. A lower dose saves money and reduces side effects and adverse events, said researcher Philip Chung, and experts hope the switch will reduce the risk of vancomycin-resistant Enterococci populations in the gastrointestinal tract.

Related Summaries